Rapid clearance of erythrodermic psoriasis with apremilast

BACKGROUND: Apremilast is a new immunomodulatory drug, a small molecule inhibitor of PDE4, which down-regulates the expression of multiple pro-inflammatory cytokines, such as tumor necrosis factor alpha, interleukin 17, interleukin 23. MAIN OBSERVATIONS: We describe a case of a 54-year-old man with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Dermatol Case Rep
Asıl Yazarlar: Papadavid, Evangelia, Kokkalis, Georgios, Polyderas, Georgios, Theodoropoulos, Konstantinos, Rigopoulos, Dimitrios
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Specjalisci Dermatolodzy 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5776028/
https://ncbi.nlm.nih.gov/pubmed/29367871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3315/jdcr.2017.1246
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller